NovoPen® 3
In 1985, Novo Nordisk introduced the first NovoPen®, revolutionising the modern treatment of diabetes and vastly improving the quality of life for people with diabetes.
NovoPen® 3 has a proven track record, as it is the most widely used insulin pen in the world. More than 3 million people around the world use NovoPen® 3 every day. NovoPen® 3 is suited for all types of regimens including intensive therapy, since the different colour versions allow easy differentiation of insulin type.
Try the interactive QuickGuide to see how easy NovoPen® 3 is to use.
NovoPen® 3 is a registered trademark of Novo Nordisk A/S.
